Xue Han
Oncology · with Chen · 2015
A researcher in the Science corpus: 1 paper; trusts 5 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Oncology — 34 citations into it; #1,440 of 1,698 by trust here, #1,453 by citations
- Immunology — 30 citations into it; #1,806 of 2,160 by trust here, #1,918 by citations
Whom Xue Han trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Xue Han overall
Papers from Xue Han's perspective
Ordered by how strongly the researchers Xue Han trusts endorse each paper. Same corpus, a different order for every researcher.
- Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity (Nature reviews. Immunology)
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells (Science Translational Medicine)
- Restoring function in exhausted CD8 T cells during chronic viral infection (Nature)
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells (Journal of Experimental Medicine)
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer (Nature)
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function (Science)
- Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. (Cancer Research)
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape (Science Translational Medicine)
- The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. (Immunity)
Their papers
- Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. (2015) — 1,205 citations